• Peace of mind for the concerned consumer

    Anatara plans to develop Detach for use in farmed animals, providing an alternative to the use of antibiotics and thereby helping farmers supply antibiotic free meat.

  • Natural treatment for animal health

    Anatara’s Detach™ is a proven natural non-antibiotic treatment for diarrhoea in piglets with the potential for use in other farm livestock. More »

  • Advancing gastrointestinal health naturally

    Our product is made using an extract from pineapple stems that blocks the causes of diarrhoea. It’s a natural product that won’t contribute to the rise of so-called “superbugs” caused by the overuse of antibiotics.

Company description

Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.

Video overview

Latest news All news

  • Anatara’s share market listing in the news

    Anatara’s Chairman Mel Bridges conducted an interview recently with the Australian Associated Press which published an article that was widely reproduced across many media outlets.

    The article highlighted that Anatara was raising $7 million in an initial public offering and would list on the Australian Securities Exchange.

    It noted that Anatara’s lead product, DetachTM is a non-antibiotic medicine made from an extract from pineapple roots to treat and prevent diarrhoea in food production animals and planned to be first used in pigs.

    The article was published on numerous widely-read news websites including The Australian, The Age, The Sydney Morning Herald, The Herald Sun, and The Daily Telegraph.

  • Obama Administration acts to combat antimicrobial resistance

    US President Barack Obama has issued an Executive Order that aims to combat the rise of antibiotic resistant bacteria that represent a serious threat to public health and the economy.

    It says the US Federal Government will work domestically and internationally to “detect, prevent, and control illness and death related to antibiotic-resistant infections by implementing measures that reduce the emergence and spread of antibiotic-resistant bacteria and help ensure the continued availability of effective therapeutics for the treatment of bacterial infections”.

    Measures to tackle antimicrobial resistance include eliminating “the use of medically important classes of antibiotics for growth promotion purposes in food-producing animals”.

    The Executive Order can be found here.

    A report to the President on combating antibiotic resistance by the President’s Council of Advisors on Science and Technology can be found here.

  • Anatara Lifesciences in The Australian newspaper

    The Anatara team met senior business journalist Tim Boreham from The Australian newspaper recently to brief him on Anatara and our plans. He notes we’re raising $7 million from investors and that we’re intending to conduct new trials to get Detach re-registered in Australia. He suggests people read our prospectus when it’s lodged.

    Read more here.